[Federal Register: May 8, 2009 (Volume 74, Number 88)]
[Notices]
[Page 21678-21679]
[DOCID:fr08my09-68]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 13383-000]

Hydro Energy Technologies, LLC; Notice of Preliminary Permit
Application Accepted for Filing and Soliciting Comments, Motions To
Intervene, and Competing Applications

May 1, 2009.
    On March 5, 2009, Hydro Energy Technologies, LLC filed an
application, pursuant to section 4(f) of the Federal Power Act,
proposing to study the feasibility of the Chagrin Spillway
Hydroelectric Project, to be located on the Upper Main Branch Chagrin
River, in Cuyahoga County, Ohio.
    The proposed Chagrin Spillway Project would be located at: (1) An
existing, privately owned mill pond dam, which is 162 feet long and 17
feet high, and (2) an existing reservoir having a maximum surface area
of 7 acres, with a water surface elevation of 946.9 feet mean sea
level.
    The proposed project would consist of: (1) A new powerhouse
containing one or more turbine/generators with a total installed
capacity of 0.2 megawatts; (2) a new 60-inch-diameter, 75-foot-long
penstock; (3) a new 250-foot-long transmission line; and (4)
appurtenant facilities. The Chagrin Spillway Project would have an
estimated average annual generation of 800 megawatts-hours, which would
be sold to a local utility.
    Applicant Contact: Mr. Anthony J. Marra, Jr., President, 31300
Solon Rd., Suite 12, Solon, Ohio 44139,<PHONE_NUMBER>.
    FERC Contact: John Ramer,<PHONE_NUMBER>.
    Deadline for filing comments, motions to intervene, competing
applications (without notices of intent), or notices of intent to file
competing applications: 60 days from the issuance of this notice.
Comments, motions to intervene, notices of intent, and competing
applications may be filed electronically via the Internet. See 18 CFR
385.2001(a)(1)(iii) and the instructions on the Commission's Web site
under the ``e-Filing'' link. If unable to be filed electronically,
documents may be paper-filed. To paper-file, an original and eight

copies should be mailed to: Kimberly D. Bose, Secretary, Federal Energy
Regulatory Commission, 888 First Street, NE., Washington, DC 20426.
    For more information on how to submit these types of filings please
go to the Commission's Web site located at http://www.ferc.gov/filing-
comments.asp. More information about this project can be viewed or
printed on the ``eLibrary'' link of Commission's Web site at http://
www.ferc.gov/docs-filing/elibrary.asp. Enter the docket number (P-
13383) in the docket number field to access the document. For
assistance, call toll-free 1-866-208-3372.

Kimberly D. Bose,
Secretary.
[FR Doc. E9-10696 Filed 5-7-09; 8:45 am]


REVISED TECHNICAL SUPPORT DOCUMENT FOR CAPROLACTAM, GLYOXAL, AND GLYOXYLIC ACID PRODUCTION: SUPPLEMENTAL PROPOSED RULE FOR THE GREENHOUSE GAS REPORTING PROGRAM

                                                    Office of Air and Radiation
                                           U.S. Environmental Protection Agency

                                                                  April 1, 2023

Contents
1.	Industry Description	1
1.1	Caprolactam	1
1.2	Glyoxal	2
1.3	Glyoxylic Acid	3
2.	Total Emissions	3
2.1	Process Emissions	4
2.1.1	Estimated N2O Emissions	4
2.1.2	Estimated CO2 Emissions	5
2.2	Stationary Combustion	6
3. 	Review of Existing Programs and Methodologies	7
3.1	Review of Existing Programs	7
3.2	Calculation Methodologies for Caprolactam, Glyoxal, and Glyoxylic Acid Production Processes	8
4.	Options for Reporting Threshold	10
5.	Options for Monitoring Methods	11
5.1	Option 1: Emission Calculation / Mass Balance	11
5.2	Option 2: Direct Measurement	12
6.	QA/QC Requirements	13
7.	Options for Estimating Missing Data	13
7.1	Procedures for Option 1: Emission Calculation / Mass Balance	13
7.2	Procedures for Option 2: Direct Measurement	13
8.	References	14

1.	Industry Description
This prospective source category consists of facilities that produce caprolactam, glyoxal, and/or glyoxylic acid. Most commercial processes for producing caprolactam, glyoxal, and/or glyoxylic acid result in nitrous oxide (N2O) emissions, so the inclusion of this source category would improve accounting of U.S. N2O emissions.
1.1	Caprolactam
Caprolactam is a crystalline solid organic compound with the chemical formula C6H11NO. Caprolactam has a wide variety of uses, including brush bristles, textile stiffeners, film coatings, synthetic leather, plastics, plasticizers, paint vehicles, cross-linking for polyurethanes, and in the synthesis of lysine. Caprolactam is primarily used in the manufacture of synthetic fibers, especially Nylon 6 (NIH, n.d.-a).
Most commercial processes used for the manufacture of caprolactam use the following sequence of reactions.
 Cyclohexanone is mostly formed from benzene, but toluene can also be used:
 Benzene is hydrogenated to cyclohexane; and
 Cyclohexane is oxidized to produce cyclohexanone, which is used in the last step below to form caprolactam.
 Ammonia is oxidized to nitric oxide (NO) and nitrogen dioxide (NO2);
 Ammonia is reacted with carbon dioxide (CO2) and water (H2O) to form ammonium carbonate;
 Ammonium carbonate is reacted with NO/NO2 to form ammonium nitrite;
 Ammonia is reacted with sulfur dioxide (SO2) and H2O to form ammonium bisulfite;
 Ammonium nitrite and ammonium bisulfite react to form hydroxylamine disulfonate;
 Hydroxylamine disulfonate is hydrolyzed to form hydroxylamine sulfate and ammonium sulfate;
 Hydroxylamine sulfate is reacted with cyclohexanone to form caprolactam through the Beckmann rearrangement (IPCC, 2006).
As of 2019, the United States had two companies that produce caprolactam with a total of two caprolactam production facilities: AdvanSix in Virginia (AdvanSix, 2020) and BASF in Texas (BASF, 2020). Caprolactam production in 2019 was estimated at 515,000 metric tons (ACC 2020).
1.2	Glyoxal
Glyoxal is a solid organic compound with the chemical formula C2H2O2. The preferred name assigned by the International Union of Pure and Applied Chemistry (IUPAC) is ethanedial. Since pure glyoxal is not stable in the atmosphere, it is typically supplied in a 40 percent by weight solution in water. Glyoxal has a wide variety of uses, including as a crosslinking agent in various polymers for paper coatings, textile finishes, adhesives, leather tanning, cosmetics, and oil-drilling fluids; as a sulfur scavenger in natural gas sweetening processes; as a biocide in water treatment; to improve moisture resistance in wood treatment; and as a chemical intermediate in the production of pharmaceuticals, dyestuffs, glyoxylic acid, and other chemicals. It is also used as a less toxic substitute for formaldehyde in some applications (e.g., in wood adhesives and embalming fluids) (Fact.MR, 2019; Ecofys et al., 2009; NIH, n.d.-b).
Commercial glyoxal may be prepared in one of two ways. The more common process is the LaPorte process, the gas-phase catalytic oxidation of ethylene glycol with air in the presence of a silver or copper catalyst (Mattioda and Blanc, 2012). This process produces CO2 as a byproduct but not N2O, due to the feedstock not containing nitrogen. The single largest production site, operated by BASF in Germany, uses the LaPorte process and has a capacity of about 60,000 mt/yr (Ecofys et al., 2009).
The less common production process is the liquid-phase oxidation of acetaldehyde with nitric acid; this process emits both N2O and CO2 and is estimated to account for less than 20 percent of total global production (Teles et al., 2015). A WeylChem Lamotte (previously Clariant) facility in France uses the acetaldehyde and nitric acid production route (Ecofys et al., 2009; Teles et al., 2015); it is not clear if any other facilities in the world use this process. The capacity of the WeylChem Lamotte facility is currently unavailable. Much of the worldwide production currently occurs in China (Fact.MR, 2019).
Total annual worldwide production estimates vary; one source estimated at between 110,000 metric tons (mt) and 170,000 mt (Ecofys et al., 2009), another estimated production at about 250,000 mt (Teles et al., 2015), and one study projected total 2019 consumption at 360,000 mt (Fact.MR, 2019).
It is unclear how much glyoxal currently is produced in the United States. A BASF unit in Geismar, Louisiana, had a capacity of about 20,000 mt (Ecofys et al., 2009), but it was shut down in 2014. Of all the facilities discussed in this section, this BASF facility is the only facility that has ever reported for any subpart in any year under the Greenhouse Gas Reporting Program (GHGRP). Emerald Carolina Chemical LLC (now Dystar Carolina Chemical Corp.) in Charlotte, North Carolina, also produced glyoxal, but the glyoxal process unit (capacity unknown) was decommissioned prior to October 2012 and at the time, the company did not intend to recommission the glyoxal process unit in the future (Cogburn, 2012).
The most recently available data reported under the Toxic Substances Control Act (TSCA) indicate that several facilities imported glyoxal in 2012 through 2016, but no facility except the BASF facility in Geismar identified themselves as a domestic manufacturer. In 2015, however, four facilities claimed that their production status (i.e., as a domestic manufacturer or as an importer) and their quantities domestically manufactured and/or imported, were confidential business information (CBI) (ChemView, 2021). Thus, it is possible that one or more of these four facilities could be a domestic manufacturer. According to the TSCA data, total nationwide production volume (i.e., the sum of the amount domestically manufactured plus the amount imported) from reporting facilities was 18.3 million pounds (lbs) (8,300 mt) in 2011, and the total production volume in each of the years between 2012 and 2015 was between 10 million lbs and 50 million lbs (about 4,500 mt to 23,000 mt). It is also possible that there are other facilities in the U.S. that do not have to report under TSCA because their total production volume is less than 25,000 lbs/yr or they are exempt from reporting because they are a small manufacturer based on their total company sales revenue.
1.3	Glyoxylic Acid
Glyoxylic acid is a solid organic compound with the chemical formula C2H2O3, and the preferred name assigned by IUPAC is Acetic Acid, 2-oxo. Glyoxylic acid is exclusively produced by the oxidation of glyoxal with nitric acid. It is used mainly in the synthesis of vanillin, allantoin, and several antibiotics like amoxicillin, ampicillin, and the fungicide azoxystrobin (Teles et al., 2015). The production process is expected to emit both N2O and CO2  (see Section 3.2 for estimation methodologies). Production capacity of glyoxylic acid worldwide is estimated to be around 80,000 mt/yr (Teles et al., 2015) or 122,000 mt/yr (for 2015) (Fior Markets, 2018). According to one market researcher, China accounted for more than 88 percent of worldwide production in 2015 (Fior Markets, 2018). In 2015, four facilities reported glyoxylic acid data under TSCA. Each of these facilities reported no domestically manufactured glyoxylic acid. Total glyoxylic acid production volume (presumably all imported) was in the range of 1 million lbs to 20 million lbs (450 mt to 9,000 mt) (ChemView, 2021). As was noted above for glyoxal, there also may be some small glyoxylic acid manufacturers that were not required to report under TSCA.
2.	Total Emissions
The ammonia oxidation step of caprolactam production results in emissions of N2O, and the ammonium carbonate step results in emissions of CO2 (IPCC, 2006); however, CO2 emissions "... from the conventional process are unlikely to be significant in well-managed plants" (IPCC, 2006). Therefore, only N2O emissions are estimated in this document. Note that abatement of N2O emissions may occur at caprolactam facilities, but any potential abatement has not been considered in emissions estimates.
The liquid-phase oxidation of acetaldehyde with nitric acid to produce glyoxal emits both N2O and CO2, but as discussed in Section 4 of this document, available methods for estimating emissions address only the N2O (Ecofys et al., 2009; IPCC, 2006). The LaPorte process for producing glyoxal generates CO2 emissions (Ecofys et al., 2009), but the source of such emissions is not described and no methods for estimating such emissions are presented in the available literature. The available methods for estimating N2O emissions that are discussed in Section 3 of this document appear to focus on process vent emissions; it appears that any emissions from equipment leaks are assumed to be small and are not calculated.
The basic reaction equation for the production of glyoxal from acetaldehyde and nitric acid is:
                    2C2H4O + 2HNO3 à 2C2H2O2 + N2O + 3H2O
The stoichiometric relationship indicates that the ratio of N2O produced to glyoxal produced will be 0.38 mt N2O/mt glyoxal; however, under commercial conditions the ratio has been determined to be approximately 0.52 mt N2O/mt glyoxal (IPCC, 2006).
Production of glyoxylic acid also produces N2O emissions (Ecofys et al., 2009; IPCC, 2006); available literature makes no mention of CO2 emissions, but it appears there might be small amounts from control of process vent streams. Glyoxylic acid is produced by the oxidation of glyoxal with nitric acid. A considerable amount of the glyoxal is overoxidized to oxalic acid, and N2O is created through this secondary reaction as follows (Teles et al., 2015; Ecofys et al., 2009):
                    2C2H2O2 + 2HNO3 à 2(COOH)2 + N2O + H2O
Available literature suggests N2O is also produced through the reduction of nitric acid in the primary reaction to produce glyoxylic acid, but this is not stated explicitly, and no chemical equation is presented.
The IPCC indicates the default uncontrolled N2O emission factor for glyoxylic acid production is 0.10 mt N2O/mt glyoxylic acid (IPCC, 2006). Note that another reference estimates the emissions are 0.2 mt N2O/mt glyoxylic acid (Teles et al., 2015).
Section 2.1 presents nationwide estimates of process-related/byproduct N2O and CO2 emissions from caprolactam, glyoxal, and glyoxylic acid production and Section 2.2 discusses estimates of carbon dioxide equivalent (CO2e) emissions from stationary combustion units at caprolactam, glyoxal, and glyoxylic acid production facilities. A summary of annual process and stationary combustion emissions for each chemical is presented in Table 1.
Table 1. Total GHG Emissions by Compound[a]
Compound
Number of Facilities
Annual Process Emissions
(million mt CO2e/yr)
Annual Stationary Combustion Emissions
(million mt CO2e/yr)
Total Emissions
(million mt CO2e/yr)
Caprolactam
2[b]
1.2[c]
1.2[d]
2.5
Glyoxal
Unknown
0.06 (estimated)
0.06 (estimated)
0.13
Glyoxylic Acid
Unknown
0 (estimated)
0 (estimated)
0 (estimated)
[a] Emissions calculated using AR5 global warming potential (GWP) values of 28 for CH4 and a GWP of 265 for N2O.
[b] AdvanSix, 2020; and BASF, 2020
[c] 2019 value from Inventory of U.S. Greenhouse Gas Emissions and Sinks: 1990-2019 of 1.4 million mt CO2e using AR4 GWP value of 298 for N2O converted to 1.2 million mt CO2e, using AR5 GWP value of 265 for N2O.
[d] Reported by facilities to GHGRP for RY2019.

2.1	Process Emissions
2.1.1	Estimated N2O Emissions
The Inventory of U.S. Greenhouse Gas Emissions and Sinks: 1990-2019 (EPA, 2021) (hereafter referred to as the U.S. GHG Inventory) estimates emissions from caprolactam processes at two U.S. facilities in 2019 to be 1.4 million mt CO2e using the GWP values from IPCC's Fourth Assessment Report (AR4), or 1.2 million mt CO2e using the GWP values from the IPCC's Fifth Assessment Report (AR5). Caprolactam, glyoxal, and glyoxylic acid production are all considered part of the same industrial source category in the U.S. GHG Inventory, but the U.S. GHG Inventory does not estimate emissions from the latter two industries due to the lack of available production data.
As noted in Section 1, reporting under TSCA indicates that the total amount of glyoxal imported and domestically manufactured in 2011 was approximately 8,300 mt and was between 4,500 mt and 23,000 mt in each of the subsequent four years, and the liquid-phase oxidation of acetaldehyde with nitric acid process is estimated to account for less than 20 percent of total production (Teles et al., 2015). As noted in Section 3.2, the IPCC estimates the default N2O control efficiency as 80 percent for both glyoxal and glyoxylic acid controls (IPCC, 2007). A global warming potential of 265 was used for N2O. Assuming half of the maximum annual production was domestically manufactured (and the other half was imported), the total annual N2O emissions from domestic production could be estimated as follows:
(23,000 mt glyoxal/yr)(0.5)(0.2)(0.52 mt N2O/mt glyoxal)(1-0.8 eff)(265)
= 63,388 mt CO2e/yr
Based on the annual TSCA reporting for 2012 through 2016, it appears that there may be no glyoxylic acid being produced in the U.S. Thus, the estimated annual N2O emissions from glyoxylic acid production are 0 mt CO2e.
2.1.2	Estimated CO2 Emissions
Assuming that all hydrocarbon feedstock in the glyoxal process that is not converted to glyoxal is either converted to CO2 in the process or vented and converted to CO2 in the control device provides an estimate of the maximum expected quantity of CO2 emissions.
The yield of glyoxal in the acetaldehyde-based process is 70 percent (Teles et al., 2015). Thus, 1.43 moles of acetaldehyde would be required to produce 1 mole of glyoxal. Converting to mass using the molecular weights of glyoxal and acetaldehyde (58 and 44, respectively) means 108 mt of acetaldehyde would be required to produce 100 mt of glyoxal (1.43*44/58=1.08). If all of the carbon in the 30 percent of the acetaldehyde that is not converted to glyoxal is ultimately converted to CO2 in flares or combustion units, then 65 mt of CO2 are generated per 100 mt of glyoxal produced (108*0.3*24/44*44/12=65). Applying this factor to the nationwide production of glyoxal using the acetaldehyde process as described above results in the following nationwide estimate of CO2 emissions:
(23,000 mt glyoxal/yr)(0.5)(0.2)(0.65 mt CO2/mt glyoxal)
= 1,500 mt CO2/yr
The yield of glyoxal in the LaPorte process is estimated between 70 and 80 percent (Mattioda and Blanc, 2012). Thus, assuming the typical yield is 75 percent, 1.33 moles of ethylene glycol would be required to produce 1 mole of glyoxal (the reaction equation indicates that 1 mole of glyoxal would be produced from 1 mole of ethylene glycol if complete conversion occurred). Converting to mass using the molecular weights of glyoxal and ethylene glycol (58 and 62, respectively) means 142 mt of ethylene glycol would be required to produce 100 mt of glyoxal (1.33*62/58=1.42). If all of the carbon in the 25 percent of the ethylene glycol that is not converted to glyoxal is ultimately converted to CO2 in flares or combustion units, then 50.4 mt of CO2 are generated per 100 mt of glyoxal produced (142*0.25*24/62*44/12=50.4). Applying this factor to the estimated nationwide production of glyoxal using the LaPorte process results in the following nationwide estimate of CO2 emissions:
(23,000 mt glyoxal/yr)(0.5)(0.8)(0.504 mt CO2/mt glyoxal)
= 4,600 mt CO2/yr
It is not clear how much of the byproducts from both glyoxal processes may be recovered or removed from the processes as liquid wastes. If the amount of carbon in such streams is significant, then the estimated CO2 emissions above would be too high.
As noted above in the discussion of nationwide N2O emissions, there is not enough evidence to suggest that glyoxylic acid is being produced in the U.S. Thus, the estimated annual nationwide CO2 emissions from glyoxylic acid production are estimated to be 0 mt CO2.
2.2	Stationary Combustion
Stationary combustion emissions occur when fossil fuels are combusted to provide energy for the manufacturing equipment and process. For the two facilities that are known to manufacture caprolactam, AdvanSix and BASF, combustion emissions are already reported to the GHGRP under subpart C (General Stationary Fuel Combustion Sources). In Reporting Year 2019, the total combustion emissions for AdvanSix are 547,000 metric tons of CO2 and minimal emissions of methane and nitrous oxide; the total combustion emissions for BASF are 667,000 metric tons of CO2 and minimal emissions of methane and nitrous oxide. For these two facilities, the total combustion emissions of 1.2 million metric tons CO2e are also on the same order of magnitude as the estimated total process emissions of 1.2 million metric tons CO2e.
To understand the general magnitude of the potential stationary combustion emissions for glyoxal production, emissions from facilities that are reporting to a similar chemical production source category, subpart V (Nitric Acid Production), were reviewed. The overwhelming majority of facilities reporting under subpart V between 2015 and 2019 also reported combustion emissions under subpart C (General Stationary Fuel Combustion Sources). In 2019, 75 percent of the facilities that reported process emissions under subpart V also reported stationary combustion emissions that were greater than the associated subpart V emissions (both in terms of mt CO2e). Combustion emissions for glyoxal production could potentially be on the same order of magnitude as the 63,388 mt CO2e emissions from the production process.
For more information on combustion-related GHG emissions (CO2, CH4, and N2O), including calculation methodologies and reporting options, refer to the General Stationary Fuel Combustion Technical Support Document (EPA, 2009a).
3. 	Review of Existing Programs and Methodologies
3.1	Review of Existing Programs
In developing GHG monitoring and reporting options for caprolactam, glyoxal, and/or glyoxylic acid manufacturing processes, a number of existing programs and guideline methodologies were reviewed. Specifically, the following programs were examined:

 2006 Intergovernmental Panel on Climate Change (IPCC) Guidelines for National Greenhouse Gas Inventories. Volume 3, Chapter 3.

 European Union (EU). Commission Implementing Regulation (EU) 2018/2066 of 19 December 2018 on the Monitoring and Reporting of Greenhouse Gas Emissions Pursuant to Directive 2003/87/EC of the European Parliament and of the Council and Amending Commission Regulation (EU) No. 601/2012. January 1, 2021. Available at:
      https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02018R2066-20210101&from=EN.

 CARB (California Air Resource Board). Unofficial Electronic Version of the Regulation for the Mandatory Reporting of Greenhouse Gas Emissions. April 2019. https://ww2.arb.ca.gov/mrr-regulation.

 Environment and Climate Change Canada (ECCC). Canada's Greenhouse Gas Quantification Requirements. Version 4.0. December 2020. http://publications.gc.ca/collections/collection_2021/eccc/En81-28-2020-eng.pdf.

 United States Environmental Protection Agency (USEPA). Greenhouse Gas Reporting Program (GHGRP).

Each of these programs were reviewed to determine their applicability to the caprolactam, glyoxal, and/or glyoxylic acid production source category and whether they contained information on the types of emissions to be reported, the calculation methodologies, and the monitoring methodologies recommended. The 2006 IPCC Guidelines specify three emissions calculations methods (IPCC, 2006). The EU requires both direct monitoring of abated N2O process emissions from all three processes and mass balance calculations of unabated N2O emissions when the abatement technology fails, or if it is technically infeasible to use abatement technology (EU, 2021). The Canadian and California programs do not require emissions calculation and reporting for caprolactam, glyoxal, or glyoxylic acid processes. While the GHGRP does not require emissions calculation and reporting for caprolactam, glyoxal, or glyoxylic acid processes, it was reviewed for applicable facilities that already report combustion emissions.
It was determined that methods for calculating GHG emissions from the 2006 IPCC Guidelines were appropriate for this source category. These methods are discussed in Section 3.2.
3.2	Calculation Methodologies for Caprolactam, Glyoxal, and Glyoxylic Acid Production Processes
Emissions estimations for the caprolactam, glyoxal, and glyoxylic acid sector are addressed in the 2006 IPCC Guidelines for National Greenhouse Gas Inventories (IPCC, 2006). The IPCC describes three methods for estimating national N2O emissions from caprolactam, glyoxal, and glyoxylic acid production, as summarized below:
Tier 1: Multiply total nationwide production quantity by the default uncontrolled N2O generation factor. Assume no control.
Tier 2: Measure plant-specific production quantities and multiply by the default uncontrolled N2O generation factor. If applicable, this quantity should also be adjusted to account for emissions control (i.e., multiply the uncontrolled emissions by the factor [1-control eff * control utilization factor]). The IPCC estimates the default control efficiency as 80 percent for both glyoxal and glyoxylic acid controls. Best practice for estimating emissions from caprolactam production dictates the use of plant-specific measurement data; therefore, no default destruction efficiency was recommended in the IPCC Guidelines for caprolactam. Plant level emissions should then be summed to calculate the nationwide emissions.
The Tier 2 monitoring method requires raw material input or output to be known in addition to a standard emission factor. In addition, Tier 2 requires site-specific knowledge of the use of N2O control technologies. Table 2 gives the default factors for Tier 2.
The equation for calculating N2O emissions is:
EN2O=i,jEFixPix1-DFjxCDUFj
Where:
EN2O 	= 	Process emissions of N2O, kilograms (kg).
EFi 	=	N2O generation factor for product i (caprolactam, glyoxal, or glyoxylic acid), kg N2O / mt of product produced.
Pi	=	Annual production of product i, (caprolactam, glyoxal, or glyoxylic acid), mt.
DFj	=	Destruction factor for control technology type j, fraction. Default is 0.8 for glyoxal and glyoxylic acid if the facility has a control device and 0 if it does not. Default is 0 for caprolactam.
CDUFj	=	Control device utilization factor for control technology type j, fraction. Use 1 if the control device has no downtime during the year and adjust downward to account for any downtime of the control device (i.e., time the device is not operating).
Table 2. Default Factors
Product
N2O Generation Factor (kg/mt product)
EFi
N2O Destruction Factor (fraction)
DFj
Control Device Utilization Factor (fraction)
CDUFi
N2O Emission Factor (kg/mt product)
EFi * (1-DFi * CDUFi)

Caprolactam
9.0
0
1.0
9.0
Glyoxal
5,200
0.8
1.0
1,040
Glyoxylic acid
1,000
0.8
1.0
200
Source: IPCC, 2006
Tier 3: Use the same calculation equation as for Tier 2, but use direct measurement to determine plant-specific uncontrolled N2O generation factors and control efficiencies. The measurements may be either flow and concentration data based on periodic sampling or based on the use of continuous emission monitoring. Also measure production at each plant. In some cases, direct measurement may instead include measurements of the GHG concentration in the stack gas and the flow rate of the stack gas using a continuous emission monitoring system (CEMS); however, there is no CEMS for N2O.
Available literature does not describe mechanisms for the generation of CO2 emissions from caprolactam production, glyoxal production, or glyoxylic acid production. One reference indicates that CO2 is the main byproduct of the LaPorte process (Teles et al., 2015); other CO2 emissions are likely from oxidation of hydrocarbons in control devices. No methods for estimating such CO2 emissions have been identified in the literature as part of this review. Based on the emission estimates in Section 2.1.2, the CO2 process emissions are small compared to the N2O process emissions or the CO2 combustion emissions. While a CEMS option could be considered for CO2 emissions, it appears unlikely that facilities currently monitor their CO2 emissions using CEMS. Therefore, CEMS are not discussed further in this document, although they would result in the most accurate emissions measurements. Either these CO2 process emissions can be neglected, or a carbon balance can be used to estimate the CO2 emissions (i.e., assume all carbon not converted to product is emitted as CO2).
4.	Options for Reporting Threshold
The requirements provided in subpart A of the GHGRP (40 CFR 98.2) specify the reporting thresholds for each direct emitter and supplier source category included under the GHGRP. These thresholds determine whether a facility's annual emissions must be reported under their respective subpart(s). For direct emitters of GHGs, reporting, monitoring, recordkeeping requirements apply to the owners and operators of any facility emitting over 25,000 mt CO2e from all direct emitter source categories, unless the facility is part of an "all-in" source category provided in Table A-3 of subpart A. If the facility is part of an "all-in" source category, they must initially report to the GHGRP under all applicable subparts regardless of their GHG emissions quantities. As part of this source category analysis, the number of facilities expected to report at different reporting thresholds was evaluated. Specifically, we evaluated the number and percent of emissions that would be reported using a 25,000 mt CO2e threshold (combined from all direct emitter source categories) versus no threshold (i.e., "all-in" subpart).
As discussed in Sections 1 and 2 of this document, there are two known facilities in the United States producing caprolactam, up to four potential facilities in the United States producing glyoxal, and no known facilities understood to produce glyoxylic acid. The two known facilities producing caprolactam already report combustion emissions to the GHGRP well above the potential 25,000 mt CO2e reporting threshold. The estimated process emissions are also well above the potential 25,000 mt CO2e reporting threshold. It is estimated that 20 percent of the glyoxal is produced using the acetaldehyde and nitric acid process, so we assumed that one of the two potential domestic producers of glyoxal uses that process. The remaining two potential glyoxal facilities are assumed to be importers with zero emissions from the production of glyoxal. The process emissions from the facility using the acetaldehyde and nitric acid process are estimated to be approximately 65,000 mt CO2e, which is greater than the reporting threshold. The process emissions from the one potential domestic producer of glyoxal assumed to be using the LaPorte process is approximately 4,600 mt CO2e per year.
Because none of the potential glyoxal manufacturers currently report to the GHGRP, it is difficult to determine which, if any, additional subparts may cause the facilities using the LaPorte process to exceed a potential 25,000 mt CO2e reporting threshold. It is likely that stationary combustion sources would be present at these facilities. However, for this analysis, we assumed all glyoxal producers using the LaPorte process were below the 25,000 mt CO2e reporting threshold because the additional LaPorte process CO2 emissions are small and unlikely to cause a facility not currently reporting to now exceed that threshold.
Table 3 summarizes the results of this threshold analysis. Adding caprolactam, glyoxal, and glyoxylic acid production as an all-in source category (i.e., regardless of their emissions profile) is a conservative approach to gather information from all applicable facilities and accounts for the uncertainty in the data and assumptions used in this emissions analysis. However, adding caprolactam, glyoxal, and glyoxylic acid production as a 25,000 mt CO2e reporting threshold category is expected to require 99.6 percent of the emissions from the source category to be reported.

           Table 3.  Evaluation of Alternative Threshold Options[a]
                            Option/Threshold Level
                             Emissions Covered[b]
                             Facilities Covered[b]

                                 mt CO2e/year
                                    Percent
                                    Number
                                    Percent
                               Option 1:  All-in
                                  1.2 million
                                      100
                                       6
                                      100
                         Option 2:  >25,000 mtCO2e
                                  1.2 million
                                     99.6
                                       3
                                      50
[a] Emissions calculated using AR5 GWPs of 28 for CH4 and a GWP of 265 for N2O.
[b] Considers process emissions only.

5.	Options for Monitoring Methods
Two separate monitoring methods were considered for this technical support document: an emission calculation for N2O and mass balance for CO2 (Option 1) and direct measurement (Option 2). Option 1 for N2O and Option 2 are based on the IPCC Tier 2 and 3 methodologies, respectively, for caprolactam. The IPCC guidelines provide the methodology for caprolactam in detail, but the introduction also specifically notes that the methodology is "suitable for application to estimation of emissions from glyoxal and glyoxylic acid" (IPCC, 2006). Option 1 for CO2 is based on other subparts in the GHGRP that use a mass balance method (e.g., subpart X). All of these options require annual reporting.
5.1	Option 1: Emission Calculation / Mass Balance
Option 1 for N2O generally follows the IPCC's Tier 2 protocol. The Tier 2 monitoring method requires raw material input or output to be known in addition to a standard emission factor. In addition, Tier 2 requires site-specific knowledge of the use of N2O control technologies. The volume or mass of each product would be measured with a flow meter or weigh scales.
The mass balance procedures for CO2 would be similar to mass balances required for existing subparts in the GHGRP such as petrochemical production (subpart X). Specifically, site-specific quantities and carbon contents of all carbon-containing feedstocks and products would be determined, and CO2 emissions would be calculated assuming all carbon from the feedstock that does not end up in product is emitted as CO2. Note that liquid wastes that are not combusted should be considered to be a product for the purposes of the mass balance emissions calculation. The volume or mass of each feedstock and product would be measured with a flow meter (other options such as weighing might also be considered). As noted above, the production quantities are expected to be small, and the CO2 process emissions relatively low. Thus, instead of measuring carbon content, the carbon content of each feedstock and product would be determined based on the quantity of each stream and the molecular formula of the applicable pure compounds, adjusted as necessary to account for significant byproducts or diluents in the stream (e.g., water in the glyoxal solution product stream). Separate equations like Equations X-1, X-2, and X-3 in 40 CFR part 98, subpart X, would be used to determine the monthly difference in carbon content between inputs and outputs (i.e., all gaseous feedstocks/products, all liquid feedstocks/products, and all solid feedstocks/products), and then summed over all months in the reporting year. The three resulting annual values would be summed and multiplied by the ratio of the molecular weight of CO2 to the atomic weight of carbon to calculate the annual mass of CO2 emissions. If process vent emissions are routed to a combustion unit that is subject to subpart C reporting, then the quantity of the vent gas should not be included in the total quantity of fuel reported under subpart C. (Note: if the N2O is controlled using something other than thermal or catalytic destruction that would not convert hydrocarbons to CO2, then this option would need to be modified for CO2. Additionally, if the quantity of carbon-containing liquid waste streams is substantial so that the difference in the amount of carbon between the feedstocks and products is small, then measurement inaccuracies may make it difficult to calculate accurate emissions.)
5.2	Option 2: Direct Measurement
For industrial source categories for which the process emissions and/or combustion GHG emissions are contained within a stack or vent, direct measurement may include periodic measurement of the GHG concentration in the stack gas and the flow rate of the stack gas using periodic stack testing on a specified schedule and whenever a plant makes any significant process changes that would affect the N2O or CO2 emission rates.
For direct measurement using stack testing, sampling equipment would be brought to the site when needed and installed temporarily in the stack to withdraw a sample of the stack gas and measure the flow rate of the stack gas. If there are any emissions controls, the testing should be conducted for both the uncontrolled stream from the process (i.e., the control device inlet) and the control device outlet. The emissions are calculated from the concentration of GHGs in the stack gas and the flow rate of the stack gas. Specifically, the results are used to develop the numerator for a site-specific emission factor (kg N2O) as well as a site-specific destruction factor for the control technology (if applicable). The volume or mass of caprolactam, glyoxal, and glyoxylic acid during the test period would be determined using flow meters (or potentially other devices) and used as the denominator in the site-specific emission factor. The factors are then used along with the site-specific production rates in the same equation as in Option 1. (One exception is that emissions from any separately vented streams to flares would be calculated as currently specified in 40 CFR 98.253 (subpart Y).) Under this Option, fugitive emissions would be assumed to be small and would not be calculated.
A stack test provides a periodic measurement of the emissions rather than continuous measurement of the emissions. A method using periodic, short-term stack testing would be appropriate for those facilities where process inputs and process operating parameters remain relatively consistent over time. In cases where there is the potential for significant variations in the process input characteristics or operating conditions, more frequent testing (or potentially continuous measurements, for CO2) would be needed to accurately record changes in the actual GHG emissions from the sources resulting from any process variations.
As in Option 1, the volume or mass of each product would be measured with a flow meter or weigh scales.
 QA/QC Requirements
In order to ensure the quality of the reported GHG emissions, the following quality assurance/quality control (QA/QC) activities are considered important:
      (1)	All meters or monitors (e.g., feedstock/product flow, gas composition, etc.) that are used to provide data for the GHG emissions calculations should be calibrated prior to the first reporting year, using a suitable method published by a consensus standards organization (e.g., ASTM, ASME, API, AGA, etc.), or as specified by the meter/monitor manufacturer. Said meters or monitors shall be recalibrated either annually or at the minimum frequency specified by the manufacturer.
      (2)	Calibration documentation should be maintained. The estimated accuracy of measurements made with these devices should also be recorded, and the technical basis for the estimates should be provided.
      (3)	All CO2 CEMS and flow rate monitors used for direct measurement of GHG emissions should comply with QA procedures for daily calibration drift checks and quarterly or annual accuracy assessments, such as those provided in Appendix F to Part 60 or similar QA procedures.
 Options for Estimating Missing Data
Options and considerations for missing data will differ depending on the proposed monitoring method. Each option would require a complete record of all measured parameters as well as parameters determined from company records that are used in the GHG emissions calculations (e.g., production rates).
7.1	Procedures for Option 1: Emission Calculation / Mass Balance
      For process sources that use an emission calculation for N2O emissions, the emission calculation is derived from default emission factors and activity data. No missing data procedures would apply for production rates because businesses closely track those rates and 100 percent data availability would be expected. For the control device utilization factor, assuming that the control device operation is generally constant from year to year, the substitute data value could be the most recent quality-assured value.
      For process sources that use a mass balance for CO2 emissions, determine substitute values for missing feedstock and product quantities using the procedures for missing fuel usage in 98.35(b)(2), and for missing feedstock and product carbon contents and molecular weights (for gaseous feedstocks and products), using the same procedures as for missing carbon contents and molecular weights specified for fuels in 98.35(b)(1).
7.2	Procedures for Option 2: Direct Measurement
      For options involving direct measurement of vent stream flow rate and composition using stack testing, "missing data" is not generally anticipated. Stack testing conducted for the purposes of compliance determination is subject to quality assurance guidelines and data quality objectives established by the U.S. EPA, including the Clean Air Act National Stack Testing Guidance published in 2009 (EPA, 2009b). The 2009 Guidance Document indicates that stack tests should be conducted in accordance with a pre-approved site- specific test plan to ensure that a complete and representative test is conducted. Results of stack tests that do not meet pre-established quality assurance guidelines and data quality objectives would generally not be acceptable for use in emissions reporting, and any such stack test would need to be re-conducted to obtain acceptable data.
      The U.S. EPA anticipates that test plans for stack tests that are expected to be used to obtain data for the purposes of emissions reporting would be made available to EPA prior to the stack test and that the results of the stack test would be reviewed against the test plan prior to the data being deemed acceptable for the purposes of emissions reporting.
      No missing data procedures would apply for production rates because businesses closely track those rates and 100 percent data availability would be expected. For the control device utilization factor, assuming that the control device operation is generally constant from year to year, the substitute data value could be the most recent quality-assured value.
 References
ACC (2020) Business of Chemistry (Annual Data). American Chemistry Council, Arlington, VA.
AdvanSix (2020). AdvanSix Hopewell Virginia Information Sheet. Accessed June 21, 2021. Available at: https://www.advan6.com/hopewell.
BASF (2020). BASF: Freeport, Texas Fact Sheet. Accessed June 21, 2021. Available at: https://www.basf.com/global/documents/en/about-us/strategy-and-organization/verbund/BASF_Freeport.pdf.
CARB (California Air Resource Board). Unofficial Electronic Version of the Regulation for the Mandatory Reporting of Greenhouse Gas Emissions. April 2019. https://ww2.arb.ca.gov/mrr-regulation.
ChemView (2021). Compilation of data submitted under TSCA in 2012 and 2016. Accessed April 2021. Available at https://chemview.epa.gov/chemview.
Cogburn, M.O. (2012). United States v. Emerald Carolina Chem., LLC. Consent Decree, Civil Action No. 3:12-cv-00554. United States District Court for the Western District of North Carolina, Charlotte Division. Decided October 25, 2012. Available at https://casetext.com/case/united-states-v-emerald-carolina-chem.
Environment and Climate Change Canada (ECCC). Canada's Greenhouse Gas Quantification Requirements. Version 4.0. December 2020. http://publications.gc.ca/collections/collection_2021/eccc/En81-28-2020-eng.pdf.
Ecofys, et al. (2009). Methodology for the free allocation of emission allowances in the EU ETS post 2012: Sector Report for the Chemical Industry. Prepared by Ecofys, Fraunhofer Institute for Systems and Innovation Research, and Oko-Institut for the European Commission. November 2009. Available at https://ec.europa.eu/clima/system/files/2016-11/bm_study-chemicals_en.pdf.
EPA (U.S. Environmental Protection Agency) (2009a). General Stationary Fuel Combustion Technical Support Document, U.S. EPA Office of Air and Radiation, January 30, 2009. Available at https://www.regulations.gov/document/EPA-HQ-OAR-2008-0508-0004.
EPA (U.S. Environmental Protection Agency) (2009b). Clean Air Act National Stack Testing Guidance, U.S. EPA Office of Enforcement and Compliance Assurance, April 27, 2009. Available at https://www.epa.gov/sites/default/files/2013-09/documents/stacktesting_1.pdf
EPA (U.S. Environmental Protection Agency) (2021). Inventory of U.S. Greenhouse Gas Emissions and Sinks: 1990-2019. EPA 430-R-21-005. April 14, 2021. Available at https://www.epa.gov/ghgemissions/inventory-us-greenhouse-gas-emissions-and-sinks-1990-2019.
EU (European Union) (2021). Commission Implementing Regulation (EU) 2018/2066 of 19 December 2018 on the Monitoring and Reporting of Greenhouse Gas Emissions Pursuant to Directive 2003/87/EC of the European Parliament and of the Council and Amending Commission Regulation (EU) No. 601/2012. January 1. Available at:  https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:02018R2066-20210101&from=EN.
Fact.MR (2019). "Glyoxal Sales Surge as a Versatile Chemical Intermediate that Complements Sustainability-driven Efforts of Manufacturers, finds Fact.MR." February 20, 2019. Accessed April 2021. Available at https://www.factmr.com/media-release/882/glyoxal-market.
Fior Markets (2018). Summary of Global Glyoxylic Acid Market by Manufacturers, Regions, Type and Application, Forecast to 2023. July 2018. Available at: https://www.fiormarkets.com/report/global-glyoxylic-acid-market-by-manufacturers-regions-type-268394.html.
IPCC (The Intergovernmental Panel on Climate Change) (2006). 2006 IPCC Guidelines for National Greenhouse Gas Inventories. Prepared by the IPCC National Greenhouse Gas Inventories Programme. H.S. Eggleston, L. Buendia, K. Miwa, T Ngara, and K. Tanabe (eds.). Hayama, Kanagawa, Japan. Available at https://www.ipcc-nggip.iges.or.jp/public/2006gl/.
IPCC Fourth Assessment Report (2007). Climate Change 2007: The Physical Science Basis. Contribution of Working Group I to the Fourth Assessment Report of the Intergovernmental Panel on Climate Change [Core Writing Team, Pachauri, R.K and Reisinger, A. (eds.)]. IPCC, Geneva, Switzerland, 104 pp. Available at: https://www.ipcc.ch/report/ar4/wg1/.
Mattioda, G., and A. Blanc (2012). "Glyoxal." Ullmann's Encyclopedia of Industrial Chemistry. Wiley-VCH Verlag GmbH & Co. KGaA. Weinheim. DOI: 10.1002/14356007.a12_491.pub2. 2012.
NIH (National Institutes of Health) (n.d.-a). "PubChem Compound Summary for CID 7768, Caprolactam." Accessed June 2021. Available at https://pubchem.ncbi.nlm.nih.gov/compound/Caprolactam.
NIH (n.d.-b). "PubChem Compound Summary for CID 7860, Glyoxal." Accessed April 2021. Available at https://pubchem.ncbi.nlm.nih.gov/compound/glyoxal.
Teles, J.H. et al. (2015). "Oxidation." Ullmann's Encyclopedia of Industrial Chemistry. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim. 10.1002/14356007.a18_261.pub2.


[Federal Register Volume 75, Number 224 (Monday, November 22, 2010)]
[Notices]
[Pages 71116-71118]
[FR Doc No: 2010-29321]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings  1

November 15, 2010.
    Take notice that the Commission received the following land
acquisition reports:

    Docket Numbers: LA10-3-000.
    Applicants: Pacific Gas and Electric Company.
    Description: Report/Form of Pacific Gas and Electric Company.
    Filed Date: 10/21/2010.
    Accession Number: 20101021-5060.
    Comment Date: 5 p.m. Eastern Time on Friday, November 19, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Bendwind, LLC; Big Sky Wind, LLC; DeGreeff DP, LLC;
DeGreeffpa, LLC; CL Power Sales Eight, L.L.C.; Coalinga Cogeneration
Company; CP Power Sales Nineteen, L.L.C.; CP Power Sales Seventeeen,
L.L.C.; CP Power Sales Twenty, L.L.C.; Edison Mission Marketing &
Trading, Inc.; Edison Mission Solutions, LLC; Elkhorn Ridge Wind, LLC;
EME Homer City Generation, L.P.; Forward WindPower, LLC; Groen Wind,
LLC; High Lonesome Mesa; Hillcrest Wind, LLC; Jeffers Wind 20, LLC;
Kern River Cogeneration Company; Loredo Ridge Wind, LLC; Larswind, LLC;
Lookout WindPower, LLC; Mid-Set Cogeneration Company; Midway-Sunset
Cogeneration Company; Midwest Generation, LLC; Mountain Wind Power,
LLC; Mountain Wind Power II, LLC; Salinas River Cogeneration Company;
San Juan Mesa Wind Project, LLC; Sargent Canyon Cogeneration Company;
Sierra Wind, LLC; Sleeping Bear, LLC; Southern California Edison
Company; TAIR Windfarm, LLC; Walnut Creek Energy, LLC; Watson
Cogeneration Company; Wildorado Wind, LLC; Taloga Wind, LLC.
    Description: Q3 2010 CIS in Dkt. No. LA10-3 of Edison
International.
    Filed Date: 10/21/2010.
    Accession Number: 20101021-5077.
    Comment Date: 5 p.m. Eastern Time on Friday, November 19, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: East Coast Power Linden Holding, LLC; Cogen
Technologies Linden Venture, L.P.; Fox Energy Company LLC; Birchwood
Power Partners, L.P.; Shady Hills Power Company, LLC; EFS Parlin
Holdings, LLC; Inland Empire Energy Center, LLC.
    Description: 3Q 2010 Site Report of GE Companies.
    Filed Date: 10/21/2010.
    Accession Number: 20101021-5102.
    Comment Date: 5 p.m. Eastern Time on Friday, November 19, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Cloud County Wind Farm LLC.
    Description: Cloud County Wind Farm LLC Notice of Non-Material
Change in Status.
    Filed Date: 10/25/2010.
    Accession Number: 20101025-5302.
    Comment Date: 5 p.m. Eastern Time on Friday, November 19, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: CinCap IV, LLC; CinCap V, LLC; Cinergy Capital Trading,
Inc.; Duke Energy Commercial Asset Management, Inc.; Duke Midwest
Operating Companies; Duke Energy Carolinas, LLC; Duke Energy Indiana,
Inc.; Duke Energy Kentucky, Inc.; Duke Energy Ohio, Inc.; Duke Energy
Retail Sales, LLC; Duke Energy Trading and Marketing, LLC; Happy Jack
Windpower, LLC; North Allegheny Wind, LLC; Silver Sage Windpower, LLC;
St. Paul Cogeneration, LLC; Three Buttes Windpower, LLC; Kit Carson
Windpower, LLC; Top of the World Energy, LLC.
    Description: Duke Energy Corporation submits Land Acquisition
Quarterly Report.
    Filed Date: 10/27/2010.
    Accession Number: 20101027-5050.
    Comment Date: 5 p.m. Eastern Time on Wednesday, November 17, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Duquesne Power, LLC; Duquesne Light Company; Duquesne
Keystone LLC; Duquesne Conemaugh LLC; Macquarie Energy LLC.
    Description: Reporting Site for New Generation Capacity Development
of Macquarie Energy LLC, et. al.
    Filed Date: 10/27/2010.
    Accession Number: 20101027-5165.
    Comment Date: 5 p.m. Eastern Time on Wednesday, November 17, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: ArcLight Energy Marketing, LLC; Coso Geothermal Power
Holdings, LLC; Oak Creek Wind Power, LLC.
    Description: Land Acquisition Site Reporting of ArcLight Energy
Marketing, LLC, Coso Geothermal Power Holdings, LLC, and Oak Creek Wind
Power, LLC.

    Filed Date: 10/28/2010.
    Accession Number: 20101028-5130.
    Comment Date: 5 p.m. Eastern Time on Thursday, November 18, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Spring Canyon Energy LLC; Judith Gap Energy LLC;
Invernergy TN LLC; Wolverine Creek Energy LLC; Grays Harbor Energy LLC;
Forward Energy LLC; Grand Ridge Energy LLC; Willow Creek Energy LLC;
Sheldon Energy LLC; Hardee Power Partners Limited; Spindle Hill Energy
LLC; Invernergy Cannon Falls LLC; Beech Ridge Energy II LLC; Grand
Ridge Energy III LLC; Grand Ridge Energy IV LLC; Grand Ridge Energy V
LLC; Vantage Wind Energy LLC; Grand Ridge Energy II LLC.
    Description: Site Report 2010 Third Quarter of Spring Canyon Energy
LLC, et. al.
    Filed Date: 10/29/2010.
    Accession Number: 20101029-5128.
    Comment Date: 5 p.m. Eastern Time on Friday, November 19, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Astoria Generating Company, L.P.; Boston Generating,
LLC; Fore River Development, LLC; Mystic I, LLC; Mystic Development,
LLC.
    Description: Quarterly Land Acquisition Report of Astoria
Generating Company, L.P.
    Filed Date: 10/29/2010.
    Accession Number: 20101029-5198.
    Comment Date: 5 p.m. Eastern Time on Friday, November 19, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Alabama Electric Marketing, LLC; Big Sandy Peaker
Plant, LLC; California Electric Marketing, LLC; Crete Energy Venture,
LLC; High Desert Power Project, LLC; Kiowa Power Partners, LLC; Lincoln
Generating Facility, LLC; New Covert Generating Company, LLC; New
Mexico Electric Marketing, LLC; Rolling Hills Generating, L.L.C.;
Tenaska Alabama Partners, Ltd.; Tenaska Alabama II Partners, L.P.;
Tenaska Frontier Partners, Ltd; Tenaska Gateway Partners, Ltd; Tenaska
Georgia Partners, L.P.; Tenaska Gateway Partners, Ltd; Tenaska Georgia
Partners, L.P.; Tenaska Power Services Co.; Tenaska Virginia Partners,
L.P.; Tenaska Washington Partners, L.P.; Tenaska Electric Marketing,
LLC; University Park Energy, LLC; Wolf Hills Energy, LLC.
    Description: Quarterly Land Acquisition Report of Alabama Electric
Marketing, LLC.
    Filed Date: 10/29/2010.
    Accession Number: 20101029-5239.
    Comment Date: 5 p.m. Eastern Time on Friday, November 19, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Niagara Generation, LLC.
    Description: Land Acquisition Report for (3Q 2010) of Niagara
Generation, LLC.
    Filed Date: 11/01/2010.
    Accession Number: 20101101-5189.
    Comment Date: 5 p.m. Eastern Time on Monday, November 22, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Iberdrola Renewables, Inc.; Atlantic Renewable Projects
II LLC; Barton Windpower LLC; Big Horn Wind Project LLC; Big Horn II
Wind Project LLC; Buffalo Ridge I LLC; Buffalo Ridge II LLC; Casselman
Windpower LLC; Colorado Green Holdings LLC; Dillon Wind LLC; Dry Lake
Wind Power, LLC; Dry Lake Wind Power II, LLC; Elk River Windfarm, LLC;
Elm Creek Wind, LLC; Elm Creek Wind II LLC; Flat Rock Windpower LLC;
Flat Rock Windpower II LLC; Flying Cloud Power Partners, LLC;
Hardscrabble Wind Power LLC; Hay Canyon Wind LLC; Juniper Canyon Wind
Power LLC; Klamath Energy LLC; Klamath Generation LLC; Klondike Wind
Power LLC; Klondike Wind Power II LLC; Klondike Wind Power III LLC;
Leaning Juniper Wind Power II LLC; Lempster Wind, LLC; Locust Ridge
Wind Farm, LLC; Locust Ridge Wind Farm II, LLC; MinnDakota Wind LLC;
Moraine Wind LLC; Moraine Wind II LLC; Mountain View Power Partners
III, LLC; Pebble Springs Wind LLC; Providence Heights Wind, LLC; Rugby
Wind LLC; Shiloh I Wind Project, LLC; Star Point Wind Project LLC;
Streator-Cayuga Ridge Wind Power LLC; Trimont Wind I LLC; Twin Buttes
Wind LLC; Northern Iowa Windpower II LLC; Farmers City Wind II LLC.
    Description: Land Acquisition Report of Iberdrola Renewables, Inc.,
et. al.
    Filed Date: 11/01/2010.
    Accession Number: 20101101-5188.
    Comment Date: 5 p.m. Eastern Time on Monday, November 22, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Arlington Valley, LLC; Bluegrass Generation Company,
L.L.C.; Bridgeport Energy LLC; DeSoto County Generating Company, LLC;
Griffith Energy LLC; Las Vegas Power Company, LLC; LS Power Marketing,
LLC; Renaissance Power, L.L.C.; Riverside Generating Company, L.L.C.;
Rocky Road Power, LLC; Tilton Energy LLC.
    Description: Quarterly Land Acquisition Report of Arlington Valley,
LLC, et al.
    Filed Date: 11/01/2010.
    Accession Number: 20101101-5190.
    Comment Date: 5 p.m. Eastern Time on Monday, November 22, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: El Dorado Energy, LLC; Elk Hills Power, LLC; Fowler
Ridge II Wind Farm LLC; Gateway Energy Services, Corp; Mesquite Power,
LLC; MXenergy Electric Inc.; San Diego Gas & Electric Company; Sempra
Energy Trading LLC; Sempra Generation; Termoelectrica U.S., LLC.
    Description: Land Acquisition Report of San Diego Gas & Electric
Company.
    Filed Date: 11/01/2010.
    Accession Number: 20101101-5199.
    Comment Date: 5 p.m. Eastern Time on Monday, November 22, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Consumers Energy Company; CMS Energy Resource
Management Company; Grayling Generating Station Limited Partnership;
Genesee Power Station Limited Partnership; CMS Generation Michigan
Power, L.L.C.; Dearborn Industrial Generation, L.L.C.
    Description: Land Acquisition Report of Consumers Energy Company,
et al.
    Filed Date: 11/01/2010.
    Accession Number: 20101101-5205.
    Comment Date: 5 p.m. Eastern Time on Monday, November 22, 2010.

    Docket Numbers: LA10-3-000.
    Applicants: Ashtabula Wind, LLC; Ashtabula Wind II, LLC; Ashtabula
Wind III, LLC; Backbone Mountain Windpower LLC; Badger Windpower, LLC;
Baldwin Wind, LLC; Bayswater Peaking Facility, LLC; Blythe Energy, LLC;
Butler Ridge Wind Energy Center, LLC; Calhoun Power Company I, LLC;
Crystal Lake Wind, LLC; Crystal Lake Wind II, LLC; Crystal Lake Wind
III, LLC; Day County Wind, LLC; Diablo Winds, LLC; Doswell Limited
Partnership; Elk City Wind, LLC; ESI Vansycle Partners, L.P.; Florida
Power & Light Company; FPL Energy Burleigh County Wind, LLC; FPL Energy
Cabazon Wind, LLC; FPL Energy Cape, LLC; FPL Energy Cowboy Wind, LLC;
FPL Energy Green Power Wind, LLC; FPL Energy Hancock County Wind, LLC;
FPL Energy Illinois Wind, LLC; FPL Energy Maine Hydro LLC; FPL Energy
Marcus Hook, L.P.; FPL Energy MH50 L.P.; FPL Energy Mower County, LLC;
FPL Energy New Mexico Wind II, LLC; FPL Energy North Dakota, LLC; FPL
Energy North Dakota, LLC FPL Oklahoma Wind, LLC; FPL Energy Oliver Wind
I, LLC; FPL Energy Oliver Wind II, LLC; FPL Energy Sooner Wind, LLC;
FPL South Dakota Wind, LLC; FPL Energy Stateline II, Inc.; FPL Energy
Vansycle, LLC; FPL Energy Wyman, LLC; FPL Energy Wyman IV, LLC; FPL
Energy Wyoming, LLC; FPLE Rode Island State Energy, L.P.; Garden Wind,
LLC; Gexa Energy LP; Gray County Wind Energy, LLC; Hawkeye Power
Partners, LLC; High Majestic Wind Energy Center, LLC; High Winds, LLC;
Jamaica Bay Peaking Facility, LLC;

Lake Benton Power Partners II, LLC; Langdon Wind, LLC; Logan Wind
Energy LLC; Meyersdale Windpower LLC; Mill Run Windpower, LLC; Minco
Wind, LLC; NextEra Energy Duane Arnold, LLC; NextEra Energy Power
Marketing, LLC; NextEra Energy Point Beach, LLC; NextEra Energy
Seabrook, LLC; Northeast Energy Associates, LP; North Jersey Energy
Associates, LP; Northern Colorado Wind Energy, LLC; Osceola Windpower,
LLC; Osceola Windpower II, LLC; Peetz Table Wind Energy, LLC;
Pennsylvania Windfarms, Inc.; Sky River LLC; Somerset Windpower, LLC;
Story Wind, LLC; Victory Garden Phase IV, LLC; Waymart Wind Farm, L.P.;
Wessington Wind Energy Center, LLC; Wilton Wind II, LLC.
    Description: Third Quarter 2010 Site Control Quarterly Filing of
the NextEra Energy Companies submitted two days out-of-time.
    Filed Date: 11/03/2010.
    Accession Number: 20101103-5119.
    Comment Date: 5 p.m. Eastern Time on Wednesday, November 24, 2010.

    Any person desiring to intervene or to protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Rules of Practice and Procedure (18 CFR 385.211 and
385.214) on or before 5 p.m. Eastern time on the specified comment
date. It is not necessary to separately intervene again in a subdocket
related to a compliance filing if you have previously intervened in the
same docket. Protests will be considered by the Commission in
determining the appropriate action to be taken, but will not serve to
make protestants parties to the proceeding. Anyone filing a motion to
intervene or protest must serve a copy of that document on the
Applicant. In reference to filings initiating a new proceeding,
interventions or protests submitted on or before the comment deadline
need not be served on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
14 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First St. NE., Washington, DC 20426.
    The filings in the above proceedings are accessible in the
Commission's eLibrary system by clicking on the appropriate link in the
above list. They are also available for review in the Commission's
Public Reference Room in Washington, DC. There is an eSubscription link
on the Web site that enables subscribers to receive e-mail notification
when a document is added to a subscribed docket(s). For assistance with
any FERC Online service, please e-mail<EMAIL_ADDRESS>or
call<PHONE_NUMBER> (toll free). For TTY, call<PHONE_NUMBER>.

Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2010-29321 Filed 11-19-10; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 78, Number 113 (Wednesday, June 12, 2013)]
[Notices]
[Pages 35279-35282]
[FR Doc No: 2013-13855]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2013-N-0618]

Agency Information Collection Activities; Proposed Collection;
Comment Request; Electronic Products

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing an
opportunity for public comment on the proposed collection of certain
information by the Agency. Under the Paperwork Reduction Act of 1995
(the PRA), Federal Agencies are required to publish notice in the
Federal Register concerning each proposed collection of information,
including each proposed extension of an existing collection of
information, and to allow 60 days for public comment in response to the
notice. This notice solicits comments on information collection
requirements for reporting and recordkeeping, general and specific
requirements, and the availability of sample electronic products for
manufacturers and distributors of electronic products.

DATES: Submit either electronic or written comments on the collection
of information by August 12, 2013.

ADDRESSES: Submit electronic comments on the collection of information
to http://www.regulations.gov. Submit written comments on the
collection of information to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852. All comments should be identified with the docket
number found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of
Information Management, Food and Drug Administration, 1350 Piccard Dr.,
PI50-400B, Rockville, MD 20850,<PHONE_NUMBER>,
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Under the PRA (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor.
``Collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes Agency requests or requirements that members of
the public submit reports, keep records, or provide information to a
third party. Section 3506(c)(2)(A) of the PRA (44 U.S.C. 3506(c)(2)(A))
requires Federal Agencies to provide a 60-day notice in the Federal
Register concerning each proposed collection of information, including
each proposed extension of an existing collection of information,
before submitting the collection to OMB for approval. To comply with
this requirement, FDA is publishing notice of the proposed collection
of information set forth in this document.
    With respect to the following collection of information, FDA
invites comments on these topics: (1) Whether the proposed collection
of information is necessary for the proper performance of FDA's
functions, including whether the information will have practical
utility; (2) the accuracy of FDA's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used; (3) ways to enhance the quality,
utility, and clarity of the information to be collected; and (4) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques, when
appropriate, and other forms of information technology.

Electronic Products--21 CFR Parts 1002 Through 1010 (OMB Control Number
0910-0025)--Extension

    Under sections 532 through 542 of the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) (21 U.S.C. 360ii through 360ss), FDA has
the responsibility to protect the public from unnecessary exposure of
radiation from electronic products. The regulations issued under these
authorities are listed in title 21 of the Code of Federal Regulations,
chapter I, subpart J, parts 1000 through 1050 (21 CFR parts 1000
through 1050).
    Section 532 of the FD&C Act directs the Secretary of the Department
of Health and Human Services (the Secretary), to establish and carry
out an electronic product radiation control program, including the
development, issuance, and administration of performance standards to
control the emission of electronic product radiation from electronic
products. The program is designed to protect the public health and
safety from electronic radiation, and the FD&C Act authorizes the
Secretary

to procure (by negotiation or otherwise) electronic products for
research and testing purposes and to sell or otherwise dispose of such
products. Section 534(g) of the FD&C Act directs the Secretary to
review and evaluate industry testing programs on a continuing basis;
and section 535(e) and (f) of the FD&C Act directs the Secretary to
immediately notify manufacturers of, and ensure correction of,
radiation defects or noncompliances with performance standards. Section
537(b) of the FD&C Act contains the authority to require manufacturers
of electronic products to establish and maintain records (including
testing records), make reports, and provide information to determine
whether the manufacturer has acted in compliance.
    The regulations under parts 1002 through 1010 specify reports to be
provided by manufacturers and distributors to FDA and records to be
maintained in the event of an investigation of a safety concern or a
product recall. FDA conducts laboratory compliance testing of products
covered by regulations for product standards in parts 1020, 1030, 1040,
and 1050.
    FDA details product-specific performance standards that specify
information to be supplied with the product or require specific
reports. The information collections are either specifically called for
in the FD&C Act or were developed to aid the Agency in performing its
obligations under the FD&C Act. The data reported to FDA and the
records maintained are used by FDA and the industry to make decisions
and take actions that protect the public from radiation hazards
presented by electronic products. This information refers to the
identification of, location of, operational characteristics of, quality
assurance programs for, and problem identification and correction of
electronic products. The data provided to users and others are intended
to encourage actions to reduce or eliminate radiation exposures.
    FDA uses the following forms to aid respondents in the submission
of information for this information collection:
     FDA Form 2579 ``Report of Assembly of a Diagnostic X-Ray
System''
     FDA Form 2767 ``Notice of Availability of Sample
Electronic Product''
     FDA Form 2877 ``Declaration for Imported Electronic
Products Subject to Radiation Control Standards''
     FDA Form 3649 ``Accidental Radiation Occurrence (ARO)''
     FDA Form 3626 ``A Guide for the Submission of Initial
Reports on Diagnostic X-Ray Systems and Their Major Components''
     FDA Form 3627 ``Diagnostic X-Ray CT Products Radiation
Safety Report''
     FDA Form 3628 ``General Annual Report (Includes Medical,
Analytical, and Industrial X-Ray Products Annual Report)''
     FDA Form 3629 ``Abbreviated Report''
     FDA Form 3630 ``Guide for Preparing Product Reports on
Sunlamps and Sunlamp Products''
     FDA Form 3631 ``Guide for Preparing Annual Reports on
Radiation Safety Testing of Sunlamps and Sunlamp Products''
     FDA Form 3632 ``Guide for Preparing Product Reports on
Lasers and Products Containing Lasers''
     FDA Form 3633 ``General Variance Request''
     FDA Form 3634 ``Television Products Annual Report''
     FDA Form 3635 ``Laser Light Show Notification''
     FDA Form 3636 ``Guide for Preparing Annual Reports on
Radiation Safety Testing of Laser and Laser Light Show Products''
     FDA Form 3637 ``Laser Original Equipment Manufacturer
(OEM) Report''
     FDA Form 3638 ``Guide for Filing Annual Reports for X-Ray
Components and Systems''
     FDA Form 3639 ``Guidance for the Submission of Cabinet X-
Ray System Reports Pursuant to 21 CFR 1020.40''
     FDA Form 3640 ``Reporting Guide for Laser Light Shows and
Displays''
     FDA Form 3147 ``Application for a Variance From 21 CFR
1040.11(c) for a Laser Light Show, Display, or Device''
     FDA Form 3641 ``Cabinet X-Ray Annual Report''
     FDA Form 3642 ``General Correspondence''
     FDA Form 3643 ``Microwave Oven Products Annual Report''
     FDA Form 3644 ``Guide for Preparing Product Reports for
Ultrasonic Therapy Products''
     FDA Form 3645 ``Guide for Preparing Annual Reports for
Ultrasonic Therapy Products''
     FDA Form 3646 ``Mercury Vapor Lamp Products Radiation
Safety Report''
     FDA Form 3647 ``Guide for Preparing Annual Reports on
Radiation Safety Testing of Mercury Vapor Lamps''
     FDA Form 3659 ``Reporting and Compliance Guide for
Television Products''
     FDA Form 3660 ``Guidance for Preparing Reports on
Radiation Safety of Microwave Ovens''
     FDA Form 3661 ``Guide for the Submission of an Abbreviated
Report on X-Ray Tables, Cradles, Film Changers, or Cassette Holders
Intended for Diagnostic Use''
     FDA Form 3662 ``Guide for Submission of an Abbreviated
Radiation Safety Report on Cephalometric Devices Intended for
Diagnostic Use''
     FDA Form 3663 ``Abbreviated Reports on Radiation Safety
for Microwave Products (Other Than Microwave Ovens)''
     FDA Form 3801 ``Guide for Preparing Initial Reports and
Model Change Reports on Medical Ultraviolet Lamps and Products
Containing Such Lamps''
    The respondents to this information collection are electronic
product and x-ray manufacturers, importers, and assemblers. The burden
estimates were derived by consultation with FDA and industry personnel,
and are based on data collected from industry, including recent product
report submissions. An evaluation of the type and scope of information
requested was also used to derive some time estimates.
    FDA estimates the burden of this collection of information as
follows:

                                                     Table 1--Estimated Annual Reporting Burden \1\
--------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                Number of
         Activity/21 CFR section                     FDA form               Number of     responses per    Total annual   Average burden    Total hours
                                                                           respondents      respondent       responses     per response         \2\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Product reports--1002.10(a)-(k)..........  3626--Diagnostic x-ray......           1,500              1.1           1,650           24             39,600
                                           3627--CT x-ray.
                                           3639--Cabinet x-ray.
                                           3632--Laser.
                                           3640--Laser light show.

                                           3630--Sunlamp.
                                           3646--Mercury vapor lamp.
                                           3644--Ultrasonic therapy.
                                           3659--TV.
                                           3660--Microwave oven.
                                           3801--UV lamps.
Product safety or testing changes--        ............................           1,000              1.5           1,500            0.5              750
 1002.11(a)-(b).
Abbreviated reports--1002.12.............  3629--General abbreviated                 60              2               120            5                600
                                            report.
                                           3661--X-ray tables, etc.
                                           3662--Cephalometric device.
                                           3663--Microwave products
                                            (non-oven).
Annual reports--1002.13(a)-(b)...........  3628--General...............           1,500              1             1,500           18             27,000
                                           3634--TV.
                                           3638--Diagnostic x-ray.
                                           3641--Cabinet x-ray.
                                           3643--Microwave oven.
                                           3636--Laser.
                                           3631--Sunlamp.
                                           3647--Mercury vapor lamp.
                                           3645--Ultrasonic therapy.
Quarterly updates for new models--         ............................               3              4                12            0.5                6
 1002.13(c).
Accidental radiation occurrence reports--  3649--ARO...................              15              6                90            2                180
 1002.20.
Exemption requests--1002.50(a) and         3642--General correspondence              10              1                10            1                 10
 1002.51.
Product and sample information--1005.10..  2767--Sample product........               5              1                 5            0.1                1
Identification information and compliance  2877--Imports declaration...           1,000             20            20,000            0.2            4,000
 status--1005.25.
Alternate means of certification--         ............................               1              2                 2            5                 10
 1010.2(d).
Variance--1010.4(b)......................  3633--General variance                   350              1               350            1.2              420
                                            request.
                                           3147--Laser show variance
                                            request.
                                           3635--Laser show
                                            notification.
Exemption from performance standards--     ............................               1              1                 1           22                 22
 1010.5(c) and (d).
Alternate test procedures--1010.13.......  ............................               1              1                 1           10                 10
Report of assembly of diagnostic x-ray     2579--Assembler report......           2,000             14            28,000            0.30           8,400
 components--1020.30(d), (d)(1), and
 (d)(2).
Microwave oven exemption from warning      ............................               1              1                 1            1                  1
 labels--1030.10(c)(6)(iv).
Laser products registration--              3637--Original equipment                  50              3               150            3                450
 1040.10(a)(3)(i).                          manufacturer (OEM) report.
                                                                        --------------------------------------------------------------------------------
    Total................................  ............................  ..............  ...............  ..............  ..............          81,460
--------------------------------------------------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
\2\ Total hours have been rounded.

                               Table 2--Estimated Annual Recordkeeping Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of                    Average burden
     Activity/21 CFR section         Number of      records per    Total annual         per         Total hours
                                   recordkeepers   recordkeeper       records      recordkeeping        \2\
----------------------------------------------------------------------------------------------------------------
Manufacturers records--1002.30             1,600           1,650       2,640,000            0.12         316,800
 and 1002.31(a).................
Dealer/distributor records--               3,000              50         150,000            0.05           7,500
 1002.40 and 1002.41............
Information on diagnostic x-ray               50               1              50            0.5               25
 systems--1020.30(g)............
Laser products distribution                   50               1              50            1                 50
 records--1040.10(a)(3)(ii).....
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............         324,375
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.
\2\ Total hours have been rounded.

                           Table 3--Estimated Annual Third-Party Disclosure Burden \1\
----------------------------------------------------------------------------------------------------------------
                                                     Number of
     Activity/21 CFR section         Number of      disclosures    Total annual   Average burden    Total Hours
                                    respondents   per respondent    disclosures   per disclosure        \2\
----------------------------------------------------------------------------------------------------------------
Technical and safety information               1               1               1              12              12
 for users--1002.3..............
Dealer/distributor records--                  50               3             150               1             150
 1002.40 and 1002.41............
Television receiver critical                   1               1               1               1               1
 component warning--
 1020.10(c)(4)..................
Cold cathode tubes--                           1               1               1               1               1
 1020.20(c)(4)..................
Information on diagnostic x-ray              100               2             200              55          11,000
 systems--1020.30(g)............
Statement of maximum line                     15               1              15              10             150
 current of x-ray systems--
 1020.30(g)(2)..................
Diagnostic x-ray system safety               100               2             200             200          40,000
 and technical information--
 1020.30(h)(1)-(h)(4)...........
Fluoroscopic x-ray system safety              15               2              30              25             750
 and technical information--
 1020.30(h)(5)-(h)(6) and
 1020.32(a)(1), (g), and (j)(4).
CT equipment--1020.33(c)-(d),                 25               2              50             150           7,500
 (g)(4), and (j)................
Cabinet x-ray systems                         30               2              60              40           2,400
 information--1020.40(c)(9)(i)-(
 c)(9)(ii)......................
Microwave oven radiation safety                1               1               1              20              20
 instructions--1030.10(c)(4)....
Microwave oven safety                          1               1               1              20              20
 information and instructions--
 1030.10(c)(5)(i)-(c)(5)(iv)....
Microwave oven warning labels--                1               1               1               1               1
 1030.10(c)(6)(iii).............
Laser products information--               1,000             1.2           1,200              20          24,000
 1040.10(h)(1)(i)-(h)(1)(vi)....
Laser product service                      1,000             1.2           1,200              20          24,000
 information--1040.10(h)(2)(i)-(
 h)(2)(ii)......................
Medical laser product                         35               1              35              10             350
 instructions--1040.11(a)(2)....
Sunlamp products instructions--               10               5              50              10             500
 1040.20........................
Mercury vapor lamp labeling--                  2               1               2               1               2
 1040.30(c)(1)(ii)..............
Mercury vapor lamp permanently                 2               1               2               1               2
 affixed labels--1040.30(c)(2)..
Ultrasonic therapy products--                  5               1               5              56             280
 1050.10(d)(1)-(d)(4), (f)(1),
 and (f)(2)(iii)................
                                 -------------------------------------------------------------------------------
    Total.......................  ..............  ..............  ..............  ..............         111,139
----------------------------------------------------------------------------------------------------------------
\1\ There are no capital costs or operating and maintenance costs associated with this collection of
  information.
\2\ Total hours have been rounded.

    The following requirements are not subject to review by OMB because
they do not constitute a ``collection of information'' under the PRA:
Sections 1002.31(c), 1003.10(a)-(c), 1003.11(a)(3) and (b), 1003.20(a)-
(h), 1003.21(a)-(d), 1003.22(a) and (b), 1003.30(a) and (b), 1003.31(a)
and (b), 1004.2(a)-(i), 1004.3(a)-(i), 1004.4(a)-(h), 1005.21(a)-(c),
and 1005.22(b). These requirements apply to the collection of
information during the conduct of investigations or audits (5 CFR
1320.4).
    The following labeling requirements are not subject to review under
the PRA because they are a public disclosure of information originally
supplied by the Federal Government to the recipient for the purpose of
disclosure to the public (5 CFR 1320.3(c)(2)): Sections 1030.10(c)(6);
1040.10(g); 1040.20(d)(1)(i), (d)(2)(i), and (d)(2)(iii); and
1040.30(c)(1).

    Dated: June 6, 2013.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2013-13855 Filed 6-11-13; 8:45 am]
BILLING CODE 4160-01-P


[Federal Register Volume 85, Number 207 (Monday, October 26, 2020)]
[Notices]
[Page 67765]
[FR Doc No: 2020-23596]

-----------------------------------------------------------------------

DEPARTMENT OF HOMELAND SECURITY

Federal Emergency Management Agency

[Internal Agency Docket No. FEMA-3543-EM; Docket ID FEMA-2020-0001]

Louisiana; Amendment No. 1 to Notice of an Emergency Declaration

AGENCY: Federal Emergency Management Agency, DHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice amends the notice of an emergency declaration for
the State of Louisiana (FEMA-3543-EM), dated September 14, 2020, and
related determinations.

DATES: This amendment was issued September 30, 2020.

FOR FURTHER INFORMATION CONTACT: Dean Webster, Office of Response and
Recovery, Federal Emergency Management Agency, 500 C Street SW,
Washington, DC 20472,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION: Notice is hereby given that the incident
period for this emergency is closed effective September 16, 2020.

    The following Catalog of Federal Domestic Assistance Numbers
(CFDA) are to be used for reporting and drawing funds: 97.030,
Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis
Counseling; 97.033, Disaster Legal Services; 97.034, Disaster
Unemployment Assistance (DUA); 97.046, Fire Management Assistance
Grant; 97.048, Disaster Housing Assistance to Individuals and
Households In Presidentially Declared Disaster Areas; 97.049,
Presidentially Declared Disaster Assistance--Disaster Housing
Operations for Individuals and Households; 97.050, Presidentially
Declared Disaster Assistance to Individuals and Households--Other
Needs; 97.036, Disaster Grants--Public Assistance (Presidentially
Declared Disasters); 97.039, Hazard Mitigation Grant.

Pete Gaynor,
Administrator, Federal Emergency Management Agency.
[FR Doc. 2020-23596 Filed 10-23-20; 8:45 am]
BILLING CODE 9111-23-P